AU-002

N/A

Report date: 2022/10/10 13:38:52
NME

Base Information

Drug NameAU-002
Drug Alias NameMALT1 inhibitorAU-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitorsT-cell antigen CD7 inhibitorsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors +[4] 
TargetsCyclin-dependent kinaseT-cell antigen CD7GTPase KRas +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAurigene Discovery Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAurigene Discovery Technologies IncExelixis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A